Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Flavonol Quercitrin Hinders GSK3 Activity and Potentiates the Wnt/β-Catenin Signaling Pathway. | Int J Mol Sci | 2022 | 36292931 | PubTator, text mining | PubMed |
| Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19. | Biomedicines | 2022 | 36289890 | PubTator, text mining | PubMed |
| TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner. | Cell Death Dis | 2022 | 36289198 | PubTator, text mining | PubMed |
| Human primed and naïve PSCs are both able to differentiate into trophoblast stem cells. | Stem Cell Reports | 2022 | 36270280 | PubTator, text mining | PubMed |
| WNT signaling at the intersection between neurogenesis and brain tumorigenesis. | Front Mol Neurosci | 2022 | 36267699 | PubTator, text mining | PubMed |
| Recent trends in fragment-based anticancer drug design strategies against different targets: A mini-review. | Biochem Pharmacol | 2022 | 36265594 | PubTator, text mining | PubMed |
| The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. | J Hematol Oncol | 2022 | 36253861 | PubTator, text mining | PubMed |
| Mammalian N1-adenosine PARylation is a reversible DNA modification. | Nat Commun | 2022 | 36253381 | PubTator, text mining | PubMed |
| Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters. | Int J Mol Sci | 2022 | 36232719 | PubTator, text mining | PubMed |
| TFEB; Beyond Its Role as an Autophagy and Lysosomes Regulator. | Cells | 2022 | 36231114 | PubTator, text mining | PubMed |
| Axon Guidance Molecules and Pain. | Cells | 2022 | 36231105 | PubTator, text mining | PubMed |
| Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival. | Cancers (Basel) | 2022 | 36230543 | PubTator, text mining | PubMed |
| TRF1 uses a noncanonical function of TFIIH to promote telomere replication. | Genes Dev | 2022 | 36229075 | PubTator, text mining | PubMed |
| Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes. | Cardiovasc Diabetol | 2022 | 36221106 | PubTator, text mining | PubMed |
| Genome-wide association study for Chagas Cardiomyopathy identify a new risk locus on chromosome 18 associated with an immune-related protein and transcriptional signature. | PLoS Negl Trop Dis | 2022 | 36215317 | PubTator, text mining | PubMed |
| Minimal residual disease in EGFR-mutant non-small-cell lung cancer. | Front Oncol | 2022 | 36212398 | PubTator, text mining | PubMed |
| Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids. | Nat Commun | 2022 | 36209212 | PubTator, text mining | PubMed |
| An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. | J Nanobiotechnology | 2022 | 36209089 | PubTator, text mining | PubMed |
| High-throughput screen to identify compounds that prevent or target telomere loss in human cancer cells. | NAR Cancer | 2022 | 36196242 | PubTator, text mining | PubMed |
| A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy. | Front Immunol | 2022 | 36189307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers?page=19